ERBB2 and breast cancer: Gene expression profiling has classified BC into four distinct intrinsic molecular subtypes as follows: luminal A (LA), luminal B (LB), epidermal growth factor receptor 2 (HER2)-enriched, and basal-like (BL) BC including triple-negative breast cancer (TNBC) [2–5].